Seizures

Guidelines for Using fMRI for Presurgical Evaluation of Epilepsy

Guidelines for Using fMRI for Presurgical Evaluation of Epilepsy

By

Functional MRI may provide a less-invasive option for evaluating memory function in patients undergoing epilepsy surgery.

Should EEG Periodic Discharges be Managed Similarly to Seizures?

Should EEG Periodic Discharges be Managed Similarly to Seizures?

By

Brain oxygenation may be compromised during periodic discharges, ultimately warranting treatment.

Seizure Reduction Likely With Surgery in Nonlesional Neocortical Epilepsy

Seizure Reduction Likely With Surgery in Nonlesional Neocortical Epilepsy

By

Nearly 60% of patients had achieved seizure freedom at last follow-up, 10 to 21 years after surgery.

EEG Patterns in Critically Ill Point to Greater Risk of Seizures

EEG Patterns in Critically Ill Point to Greater Risk of Seizures

By

Careful monitoring of EEG patterns is a useful way to stratify seizure risk in critically ill patients.

VIDEO: Identifying Risk Factors for Post-Stroke Epilepsy

VIDEO: Identifying Risk Factors for Post-Stroke Epilepsy

By

Beate Diehl, MD, PhD, FRCP, discusses her research on post-stroke epilepsy.

VIDEO: Gap in Provider Knowledge Delays Diagnosis, Treatment of Infantile Spasms

VIDEO: Gap in Provider Knowledge Delays Diagnosis, Treatment of Infantile Spasms

By

Shaun Hussain, MD, MS, discusses a gap in health care provider knowledge that may contribute to the delay in the diagnosis and treatment of infantile spasms.

VIDEO: Elizabeth Thiele, MD, PhD Discusses Latest Cannabidiol Research

VIDEO: Elizabeth Thiele, MD, PhD Discusses Latest Cannabidiol Research

By

Elizabeth Thiele, MD, PhD discusses results from her research on cannabidiol in Lennox-Gastaut syndrome.

Significant Drug-Drug Interactions With Cannabidiol and Antiepileptics

Significant Drug-Drug Interactions With Cannabidiol and Antiepileptics

By

Clobazam had been previously identified as an AED with a significant interaction with CBD.

VIDEO — Industry Update: Justin Gover, CEO, GW Pharmaceuticals on Epidiolex Status

VIDEO — Industry Update: Justin Gover, CEO, GW Pharmaceuticals on Epidiolex Status

By

Justin Gover, CEO of GW Pharmaceuticals, the parent company of Greenwich Biosciences, discusses the status of the company's cannabidiol product Epidiolex on the heels of positive results from several placebo-controlled trials in epileptic syndromes.

Social Support a Significant Factor in Development of Anxiety, Depression in Epilepsy

Social Support a Significant Factor in Development of Anxiety, Depression in Epilepsy

By

Number of AEDs and seizure frequency also influenced depression in people with epilepsy.

Accurate Surgical Localization Using Combined Imaging Approach in Epilepsy

Accurate Surgical Localization Using Combined Imaging Approach in Epilepsy

By

Concordant EEG/fMRI and ESI predicted outcomes with 100% sensitivity and specificity.

Factors Predictive of Everolimus Efficacy in Tuberous Sclerosis Complex

Factors Predictive of Everolimus Efficacy in Tuberous Sclerosis Complex

By

Adjunctive everolimus treatment has been found to significantly reduce frequency of treatment-resistant seizures in TSC.

A Novel Risk Score for Seizures After Stroke

A Novel Risk Score for Seizures After Stroke

By

The triple-validated SeLECT score may help identify patients suited for antiepileptic drug trials.

Cannabidiol Reduces Seizure Frequency in Refractory Dravet Syndrome

Cannabidiol Reduces Seizure Frequency in Refractory Dravet Syndrome

By

Results of the phase 3, placebo-controlled trial support previous findings from an expanded-access program.

Brain Atrophy May Help Predict Surgical Outcomes in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

Brain Atrophy May Help Predict Surgical Outcomes in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

By

Atrophy in areas outside of the MTLE-HS network may predict poor surgical outcomes.

Major Provider Knowledge Gap Delays Diagnosis, Treatment of Infantile Spasms

Major Provider Knowledge Gap Delays Diagnosis, Treatment of Infantile Spasms

By

Less than 30% of patients were seen by an effective provider within 1 week of onset of infantile spasms.

Potential Reduction in Seizure Frequency With Statin Therapy

Potential Reduction in Seizure Frequency With Statin Therapy

By

Half of patients experienced a reduction in seizure frequency after statin initiation.

Polypharmacy Alone Worsens Quality of Life in Epilepsy

Polypharmacy Alone Worsens Quality of Life in Epilepsy

By

Awareness of the effects of polypharmacy on patient well-being is an important component of care.

Cannabidiol Helps Reduce Frequency of Drop Seizures in Lennox-Gastaut Syndrome

Cannabidiol Helps Reduce Frequency of Drop Seizures in Lennox-Gastaut Syndrome

By

Patients taking cannabidiol experienced a significant reduction in drop seizures compared with placebo.

What to Expect at the 2016 American Epilepsy Society Annual Meeting

What to Expect at the 2016 American Epilepsy Society Annual Meeting

By

Michael Privatera, MD, AES president spoke with Neurology Advisor about some of the key topics and presentations slated for this year's meeting.

Increased Physical, Mental Comorbidity in Veterans With Epilepsy

Increased Physical, Mental Comorbidity in Veterans With Epilepsy

By

Veterans with epilepsy could benefit from evidence-based chronic disease self-management programs that target physical and psychiatric comorbidities.

Deviations From Recommended Care in Pediatric Seizure

Deviations From Recommended Care in Pediatric Seizure

Lack of adherence has been linked to increased risks of intubation and ICU admission.

Left Temporal Lobe Resection Linked to Naming Decline in Refractory Epilepsy

Left Temporal Lobe Resection Linked to Naming Decline in Refractory Epilepsy

By

Those with older age at seizure onset are at the greatest risk for decline in naming ability.

Spike Localization May Predict Cognitive Outcomes in BECTS

Spike Localization May Predict Cognitive Outcomes in BECTS

By

Patients with these EEG characteristics may benefit from early screening and intervention.

Everolimus Safe, Effective for Reduction of Seizures in Tuberous Sclerosis Complex

Everolimus Safe, Effective for Reduction of Seizures in Tuberous Sclerosis Complex

By

The EXIST-3 trial is the first phase 3 study to evaluate the use of EVE for the adjunctive treatment of seizures in TSC.

FDA Approves IV Formulation of Carbamazepine for Seizures

FDA Approves IV Formulation of Carbamazepine for Seizures

By

The drug is the first and only IV formulation of the antiepileptic carbamazepine.

Super-Refractory Status Epilepticus Poses a Significant Health and Economic Burden

Super-Refractory Status Epilepticus Poses a Significant Health and Economic Burden

By

On average, pediatric patients spent more time in the ICU and accounted for a larger hospitalization cost.

Abnormal VEEG Is a Risk Factor for Recurrence After First Unprovoked Seizure

Abnormal VEEG Is a Risk Factor for Recurrence After First Unprovoked Seizure

By

VEEG abnormalities were detected in 56.7% of patients, and these were a statistically significant predictor of recurring seizure.

Lacosamide Monotherapy Safe, Effective for Long-Term Tx of Partial-Onset Seizures

Lacosamide Monotherapy Safe, Effective for Long-Term Tx of Partial-Onset Seizures

By

Results from a 2-year extension study confirm the safety and efficacy of lacosamid monotherapy.

Predicting Brain Atrophy Severity in Super-Refractory Status Epilepticus

Predicting Brain Atrophy Severity in Super-Refractory Status Epilepticus

By

Surprisingly, the authors found that change in VBR did not correlate with functional outcomes.

Sign Up for Free e-newsletters